The Coronavirus Disease 2019 (COVID-19) pandemic has resulted in significant morbidity
and mortality worldwide. Although initial reports concentrated on severe respiratory illness …

Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

A hypercoagulable state associated with coronavirus disease 2019 (COVID-19) has been
well documented and is believed to be strongly supported by a proinflammatory state. The …

Shortly after the emergence of coronavirus disease 2019 (COVID-19) in late 2019, clinicians
rapidly recognized an apparent association between the disease and both arterial and …

Abstract Severe coronavirus (COVID-19) infection has been reportedly associated with a
high risk of thromboembolism. Developing macrovascular thrombotic complications …

A prothrombotic state is reported with severe COVID-19 infection, which can manifest in
venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease …

Coronavirus disease 2019 (COVID-19) is a systemic disease that can be life-threatening
involving immune and inflammatory responses, and that can result in potentially lethal …

Introduction The first patients with Coronavirus disease 2019 (COVID-19) emerged at the
end of 2019. This novel viral infection demonstrated unique features that include …

Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has been associated with
coagulation dysfunction which predisposes patients to an increased risk of both venous and …

Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …